EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study

Emma F Avery, Julia N Kleynhans, Bruno Ledergerber, Isabella C Schoepf, Christian W Thorball, Neeltje A Kootstra, Peter Reiss, Lene Ryom, Dominique L Braun, Maria C Thurnheer, Catia Marzolini, Marco Seneghini und 8 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Emma F Avery und 19 weiteren Autor:innen. Beteiligte Einrichtung: University Department of Medicine and Infectious Diseases Service, Kantonsspital Baselland, University of Basel, Bruderholz, Switzerland. Hauptthemen laut MEDLINE: Coronary Artery Disease, HIV Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

People with human immunodeficiency virus (HIV; PWH) have increased cardiovascular risk. Higher leukocyte count has been associated with coronary artery disease (CAD) events in the general population. It is unknown whether the leukocyte-CAD association also applies to PWH.

Methods

In a case-control study nested within the Swiss HIV Cohort Study, we obtained uni- and multivariable odds ratios (OR) for CAD events, based on traditional and HIV-related CAD risk factors, leukocyte count, and confounders previously associated with leukocyte count.

Results

We included 536 cases with a first CAD event (2000–2021; median age, 56 years; 87% male; 84% with suppressed HIV RNA) and 1464 event-free controls. Cases had higher latest leukocyte count before CAD event than controls (median [interquartile range], 6495 [5300–7995] vs 5900 [4910–7200]; P < .01), but leukocytosis (>11 000/µL) was uncommon (4.3% vs 2.1%; P = .01). In the highest versus lowest leukocyte quintile at latest time point before CAD event, participants had univariable CAD-OR = 2.27 (95% confidence interval, 1.63–3.15) and multivariable adjusted CAD-OR = 1.59 (1.09–2.30). For comparison, univariable CAD-OR for dyslipidemia, diabetes, and recent abacavir exposure were 1.58 (1.29–1.93), 2.19 (1.59–3.03), and 1.73 (1.37–2.17), respectively. Smoking and, to a lesser degree, alcohol and ethnicity attenuated the leukocyte-CAD association. Leukocytes measured up to 8 years before the event were significantly associated with CAD events.

Conclusions

PWH in Switzerland with higher leukocyte counts have an independently increased risk of CAD events, to a degree similar to traditional and HIV-related risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseHIV InfectionsHumansMaleMiddle AgedFemaleLongitudinal StudiesHIVCase-Control StudiesCohort StudiesRisk FactorsLeukocyte Count

Stichwörter der Autor:innen

HIV infectioncoronary artery diseaseleukocytesmultivariable analysiswhite blood cells

Autor:innen und Institutionen

  • University Department of Medicine and Infectious Diseases Service, Kantonsspital Baselland, University of Basel, Bruderholz, Switzerland.
  • Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Hepatology, Department for Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Philip E Tarr

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Avery, E. F., Kleynhans, J. N., Ledergerber, B., Schoepf, I. C., Thorball, C. W., Kootstra, N. A., Reiss, P., Ryom, L., Braun, D. L., Thurnheer, M. C., Marzolini, C., Seneghini, M., Bernasconi, E., Cavassini, M., Buvelot, H., Kouyos, R. D., Fellay, J., Günthard, H. F., Tarr, P. E., & Swiss HIV Cohort Study (2023). Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad033

Vancouver

Avery EF, Kleynhans JN, Ledergerber B, Schoepf IC, Thorball CW, Kootstra NA, et al. Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad033

BibTeX
@article{Avery2023,
  author = {Avery, Emma F and Kleynhans, Julia N and Ledergerber, Bruno and Schoepf, Isabella C and Thorball, Christian W and Kootstra, Neeltje A and Reiss, Peter and Ryom, Lene and Braun, Dominique L and Thurnheer, Maria C and Marzolini, Catia and Seneghini, Marco and Bernasconi, Enos and Cavassini, Matthias and Buvelot, Hélène and Kouyos, Roger D and Fellay, Jacques and Günthard, Huldrych F and Tarr, Philip E and Swiss HIV Cohort Study, Swiss HIV Cohort Study},
  title = {Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad033}
}
Kostenlos starten →